Evidence map›Paper›PMID 35486812›Full record

ArticleJMIR public health and surveillance2022

A Novel Tool for Real-time Estimation of Epidemiological Parameters of Communicable Diseases Using Contact-Tracing Data: Development and Deployment.

Bernard C Silenou, Carolin Verset, Basil B Kaburi, Olivier Leuci, Stéphane Ghozzi, Cédric Duboudin, Gérard Krause

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. The evolving epidemiology of monkeypox virus.Cytokine & growth factor reviews · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bernard C SilenouDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0002-4826-0042
Carolin VersetAgence Régionale de Santé de Bourgogne Franche-Comté, Dijon, France.ORCID 0000-0003-2398-4076
Basil B KaburiDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0003-4601-3424
Olivier LeuciAgence Régionale de Santé de Bourgogne Franche-Comté, Dijon, France.ORCID 0000-0003-2240-6071
Stéphane GhozziDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0002-3911-9573
Cédric DuboudinAgence Régionale de Santé de Bourgogne Franche-Comté, Dijon, France.ORCID 0000-0002-8554-2751
Gérard KrauseDepartment of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.ORCID 0000-0003-3328-8808

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Surveillance Outbreak Response Management and Analysis System (SORMAS) contains a management module to support countries in their epidemic response. It consists of the documentation, linkage, and follow-up of cases, contacts, and events. To allow SORMAS users to visualize data, compute essential surveillance indicators, and estimate epidemiological parameters from such network data in real-time, we developed the SORMAS Statistics (SORMAS-Stats) application.

objectiveThis study aims to describe the essential visualizations, surveillance indicators, and epidemiological parameters implemented in the SORMAS-Stats application and illustrate the application of SORMAS-Stats in response to the COVID-19 outbreak.

methodsBased on findings from a rapid review and SORMAS user requests, we included the following visualization and estimation of parameters in SORMAS-Stats: transmission network diagram, serial interval (SI), time-varying reproduction number R(t), dispersion parameter k, and additional surveillance indicators presented in graphs and tables. We estimated SI by fitting lognormal, gamma, and Weibull distributions to the observed distribution of the number of days between symptom onset dates of infector-infectee pairs. We estimated k by fitting a negative binomial distribution to the observed number of infectees per infector. Furthermore, we applied the Markov Chain Monte Carlo approach and estimated R(t) using the incidence data and the observed SI computed from the transmission network data.

resultsUsing COVID-19 contact-tracing data of confirmed cases reported between July 31 and October 29, 2021, in the Bourgogne-Franche-Comté region of France, we constructed a network diagram containing 63,570 nodes. The network comprises 1.75% (1115/63,570) events, 19.59% (12,452/63,570) case persons, and 78.66% (50,003/63,570) exposed persons, including 1238 infector-infectee pairs and 3860 transmission chains with 24.69% (953/3860) having events as the index infector. The distribution with the best fit to the observed SI data was a lognormal distribution with a mean of 4.30 (95% CI 4.09-4.51) days. We estimated a dispersion parameter k of 21.11 (95% CI 7.57-34.66) and an effective reproduction number R of 0.9 (95% CI 0.58-0.60). The weekly estimated R(t) values ranged from 0.80 to 1.61.

conclusionsWe provide an application for real-time estimation of epidemiological parameters, which is essential for informing outbreak response strategies. The estimates are commensurate with findings from previous studies. The SORMAS-Stats application could greatly assist public health authorities in the regions using SORMAS or similar tools by providing extensive visualizations and computation of surveillance indicators.

Indexed as

Communicable DiseasesCOVID-19Basic Reproduction NumberContact TracingDisease OutbreaksHumansbasic reproduction numbercontact tracingCOVID-19digital health applicationdisease outbreakepidemiologyinfectious disease incubation periodoutbreak responsepandemicpublic healthresponse strategyserial intervalsuperspreading eventssurveillance tooltelemedicine

Identifiers

PMID35486812
PMCPMC9159465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.